Obicetrapib: Reversing the Tide of CETP Inhibitor Disappointments.
- Published in:
- Current Atherosclerosis Reports, 2024, v. 26, n. 2, p. 35, doi. 10.1007/s11883-023-01184-1
- By:
- Publication type:
- Article
Works matching IS 15233804 AND DT 2024 AND VI 26 AND IP 2
Results: 2
1
2
Targeting the Gut Microbiome to Treat Cardiometabolic Disease.
- Published in:
- Current Atherosclerosis Reports, 2024, v. 26, n. 2, p. 25, doi. 10.1007/s11883-023-01183-2
- By:
- Publication type:
- Article